lilly retatrutide trial Retatrutide, Eli Lilly's next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli Lilly's triple agonist, retatrutide, demonstrated

In recent years, the effects of GLP-1 agonists/analogues on the CNS have gained relevance due to emerging evidence supporting the neuroprotective effects of these molecules

Besides helping people weigh their own risks and benefits, this could help better tailor new versions of these drugs in the pipeline (and there are many ) to hopefully minimize the negative impacts as best possible

A potent blocker of CPT1, rate limiting for fatty acid metabolism and hence lipid metabolism, called Etomoxir is able to reverse the shift in metabolism, thereby favouring glucose metabolism as an energy source rather than lipids 16,17,18

Glutathione, often called the body's master antioxidant, plays a key role in detoxification by binding to a wide variety of toxins and helping remove them from the body